Characterization of patients with Human Immunodeficiency Virus positive for meningeal cryptococcosis diagnosed by cerebrospinal fluid study at Regional Teaching Hospital of Ambato

Authors

Keywords:

VIH, CRYPTOCOCCOSIS, CEREBROSPINAL FLUID, OPPORTUNISTIC INFECTIONS, BIOMARKERS.

Abstract

Introduction: Human Immunodeficiency Virus is a global health problem, which leads to the development of opportunistic infections in patients.

Objective: to characterize patients with Human Immunodeficiency Virus positive for meningeal cryptococcosis.

Methods: observational, descriptive, cross-sectional study in patients with Human Immunodeficiency Virus positive to meningeal cryptococcosis diagnosed by cerebrospinal fluid study in the Regional Teaching Hospital of Ambato in the period 2018-2021. The sample (n=155) was selected by simple random sampling.

Results: male sex (78,7 %) and ages between 31 and 40 years (36,1 %) predominated; the main symptomatology was headache (69 %), fever (42,6 %) and nausea (31 %). 22,6 % of the patients were not adherent to antiretrovirals, 23,2 % had CD4 count < 500/mm3 and 43,9 % were drug users. Of the patients, 51,6 % had values higher than 100 mg/ dL protein, 51 % had values lower than 29 mg/ dL glucose in cerebrospinal fluid. Protein alterations were associated with CD4 levels (p<0.01) and viral load (p<0,05).

Conclusions: patients with Human Immunodeficiency Virus of male sex, aged between the third and fourth decade of life, who do not adhere to antiretroviral therapy and/or consume drugs are prone to the development of meningeal cryptococcosis. Cytochemical analysis of cerebrospinal fluid is useful as a biomarker of unfavorable prognosis in patients with meningeal cryptococcosis.

Downloads

Download data is not yet available.

References

1. Islam S, Shukla S, Bajpai VK, Han YK, Huh YS, Kumar A, et al. A smart nanosensor for the detection of human immunodeficiency virus and associated cardiovascular and arthritis diseases using functionalized graphene-based transistors. Biosens Bioelectron [Internet]. 2019 [citado 11/11/2022]; 126: 792–9. Disponible en: https://www.sciencedirect.com/science/article/pii/S0956566318309382

2. Autenrieth CS, Beck EJ, Stelzle D, Mallouris C, Mahy M, Ghys P. Global and regional trends of people living with HIV aged 50 and over: Estimates and projections for 2000–2020. PLoS One [Internet]. 2018 [citado 11/11/2022]; 13(11): e0207005. Disponible en: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0207005

3. Hurtado JC, Castillo P, Fernandes F, Navarro M, Lovane L, Casas I, et al. Mortality due to Cryptococcus neoformans and Cryptococcus gattii in low-income settings: an autopsy study. Sci Reports [Internet]. 2019 [citado 11/11/2022]; 9(1): 1–10. Disponible en: https://www.nature.com/articles/s41598-019-43941-w

4. Lizarazo J, Castañeda E. Consideraciones sobre la criptococosis en los pacientes con sida. Infectio [Internet]. 2012 [citado 11/11/2022]; 16(Supl3): 94–9. Disponible en: https://prueba.revistainfectio.org/index.php/infectio/article/download/577/557

5. Williamson PR, Jarvis JN, Panackal AA, Fisher MC, Molloy SF, Loyse A, et al. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat Rev Neurol [Internet]. 2017 [citado 11/11/2022]; 13(1): 13–24. Disponible en: https://www.nature.com/articles/nrneurol.2016.167

6. Rajasingham R, Smith R, Par B. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis [Internet]. 2017 [citado 11/11/2022]; 17(8): 873–81. Disponible en: https://www.sciencedirect.com/science/article/pii/S1473309917302438

7. Zurita J, Denning DW, Paz-Y-Miño A, Solís MB, Arias LM. Serious fungal infections in Ecuador. Eur J Clin Microbiol Infect Dis [Internet]. 2017 [citado 11/11/2022]; 36(6): 975–81. Disponible en: https://doi.org/10.1007/s10096-017-2928-5

8. Pullen MF, Hullsiek KH, Rhein J, Musubire AK, Tugume L, Nuwagira E. Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials. Clin Infect Dis [Internet]. 2020 [citado 11/11/2022]; 71(7): 45–9. Disponible en: https://academic.oup.com/cid/article-abstract/73/9/e3077/6009074

9. Abassi M, Bangdiwala A, Nuwagira E. Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis. Clin Infect Dis [Internet]. 2021 [citado 11/11/2022]; 73(9):e3077–82. Disponible en: https://academic.oup.com/cid/article/73/9/e3077/6009074?login=true

10. Ávila D, Villalobos M. Perfil epidemiológico y respuesta terapéutica de la infección por Cryptococcus sp. en pacientes de Costa Rica en el Hospital San Juan de Dios, Período 2008-2012. Rev Clínica la Esc Med la Univ Costa Rica [Internet]. 2016 [citado 11/11/2022]; 6(1): 8–30. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=63835

11. Castro-Vásquez C, Maldonado DC, Arboleda P, Camargo M, Chavarro O, Díaz G. Caracterizando al enemigo: Infecciones oportunistas en el sistema nervioso central en pacientes con VIH, una serie de casos colombiana. Neurología Argentina [Internet]. 2022 [citado 11/11/2022]; 14(4): 215-220. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1853002821000951

12. Castellanos-Bertot Y, Correa-Iznaga L, Stay-Calvo S. Caracterización clínico-epidemiológica de pacientes con VIH/sida en el municipio Manuel Tames, Guantánamo. Rev Inf Científica [Internet]. 2021 [citado 11/11/2022]; 100(6): e4968 Disponible en: https://revinfcientifica.sld.cu/index.php/ric/article/view/3577/4968

13. Barbosa-Ramos RL, González-Rodríguez R. Propuesta de intervención educativa sobre VIH/Sida para adolescentes de un consultorio médico. Univ Médica Pinareña [Internet]. 2020 [citado 11/11/2022]; 16(3): e757. Disponible en: https://revgaleno.sld.cu/index.php/ump/article/view/412/757

14. Ancona-Castro C, Barrón-Hernández Y, Arenas R. Neurocryptococcosis: Demographic, Clinical and Paraclinical Characteristics in a Case Series Study. Dermatologia, Cosmet medica y Quir [Internet]. 2016 [citado 11/11/2022]; 14(3): 19-203. Disponible en: https://www.medigraphic.com/pdfs/cosmetica/dcm-2016/dcm163d.pdf

15. Aveiro A, Fretes Lezcano V, Real Delor R, Marín Ricart M. Clinical characteristics of cerebral cryptococcosis in HIV-infected patients: Hospital Nacional de Paraguay years 2012 to 2020. Rev. Nac. (Itauguá) [Internet]. 2021 [citado 11/11/2022]; 13(1): 76–87. Disponible en: http://scielo.iics.una.py/scielo.php?pid=S2072-81742021000100076&script=sci_arttext

16. Taimal Sárez CM, Reiban Espinoza EA, Flores Siranaula GM, Chuquitarco Marín PA. Alteraciones hematológicas asociadas a terapia antirretroviral en pacientes infectados por el virus de inmunodeficiencia humana. Salud, Cienc. y Tecnol [Internet]. 2022 [citado 11/11/2022]; 2(S1): 208. Disponible en: https://revista.saludcyt.ar/ojs/index.php/sct/article/view/208

Published

2023-04-24

How to Cite

1.
Santamaria-Acosta CA, Wong-Vásquez L, Labrada-González E. Characterization of patients with Human Immunodeficiency Virus positive for meningeal cryptococcosis diagnosed by cerebrospinal fluid study at Regional Teaching Hospital of Ambato. Rev Ciencias Médicas [Internet]. 2023 Apr. 24 [cited 2025 Dec. 11];27(1):e6007. Available from: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/6007

Issue

Section

ORIGINAL ARTICLES